The global autogenous vaccines market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Autogenous vaccines for veterinary can be defined as any immunological veterinary medicinal products which are manufactured for the purpose of producing active immunity from pathogenic organisms obtained from an animal which have the same herd that has been inactivated and used for the treatment of this animal. Autogenous vaccines are derived from pathogens. The growing focus on launching better and more effective products to prevent diseases in animals are paving the way for the growth of the market. Many animals get affected by various contagious diseases which include peste de petits ruminants (RRR) or goat plague, which is a major challenge in the animal healthcare segment.
(Get 15% Discount on Buying this Report)
A full report of Global Autogenous Vaccines Market is available at: https://orionmarketreports.com/autogenous-vaccines-market-2/98237/
Some major players in the market include Ceva Santé Animale, Elanco Animal Health, and Phibro Animal Health Corp., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2019, IDT Biologika, a company in the veterinary biopharmaceutical sphere, was acquired by Ceva Santé Animale (‘Ceva’). This is set to consolidate its market position in animal health products. Additionally, in October 2019, Ceva entered into a license agreement with PROBIOGEN for the manufacture of vectorized poultry vaccines using ProBioGen’s proprietary AGE1.CR technology. In August 2019, Phibro Animal Health Corp. acquired the business and assets of Osprey Biotechnics, Inc, a developer, manufacturer, and marketer of microbial products and bioproducts for a variety of animal health applications.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By End-User
- By Strain
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Ceva Santé Animale, Elanco Animal Health, and Phibro Animal Health Corp., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Autogenous Vaccines Market Report by Segment
By Type
- Poultry
- Fish
- Pigs and Cattle
By End-User
- Livestock Farming Companies
- Veterinary Research Institutes
- Veterinary Clinic
- Hospitals
By Strain
- Bacterial Strain
- Viral Strain
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
